Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Weatherford International held its shareholder meetings, approving all routine matters including director elections and auditor ratification. However, the proposal to redomesticate the company from Ireland to Texas did not achieve the required 75% supermajority despite majority support. The company plans to re-engage shareholders and present an upd…
Genco Shipping & Trading Limited's Board of Directors reaffirms its commitment to protect shareholder interests by maintaining its Shareholder Rights Agreement to prevent a hostile takeover by Diana Shipping Inc. The Board encourages shareholders to vote in favor of continuing the Rights Agreement and reelect its current directors while rejecting D…
Ingredion Incorporated, a global ingredient solutions provider, has appointed Kenneth Escoe to its board of directors effective July 1. Escoe brings extensive leadership experience across capital-intensive businesses, focusing on operations, commercial strategy, and M&A, which is expected to support Ingredion's long-term growth.
Insight Molecular Diagnostics announced publication in the American Journal of Transplantation demonstrating the superior diagnostic performance of its GraftAssure Combination Model (CM)-score assay for detecting kidney transplant rejection. The CM-score, integrating relative and absolute donor-derived cell-free DNA measurements, shows increased po…
Zenas BioPharma, a clinical-stage biopharmaceutical company focused on autoimmune diseases, announced that its management will present at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit. The presentation will cover their latest developments and will be available on-demand starting June 15, 2026.
Seneca Foods Corporation reported increased net sales and improved gross margins for the fiscal year ended March 31, 2026, achieving record full-year FIFO diluted EPS of $14.15. The company also completed the acquisition of the U.S. Green Giant Frozen business, expanding its frozen product segment and market footprint. Quarterly results also showed…
Eos Energy Enterprises, a US-based innovator in zinc-based long-duration energy storage, announced the record date for a rights offering aimed at raising funds to support its capital contribution to the Frontier Power USA joint venture. Eligible holders of common stock and warrants will receive subscription rights to purchase units at a discount, i…
Helen Suzanne L, potentially acting as part of a broader group, liquidated a portion of her Mohawk Industries Inc. (NYSE: MHK) holdings on June 9, 2026. The transaction, executed indirectly through PASTrust fbo Suzanne Helen, totaled $697,152 across multiple market orders. Despite the insider selling, recent financial data shows Mohawk Industries e…
Aggregated Bank of America credit and debit card data analyzed by analyst Justin Post shows online spending rose 13% year-over-year in May, a 2 percentage point acceleration from April. E-commerce growth exceeded brick-and-mortar retail, with online penetration climbing to 29.8% in May. The data highlights category-level shifts and signals continue…
Shaun Marklew, Chief Technology Officer at Boxlight Corp (NASDAQ: BOXL), executed a small-scale sale of company stock on November 25, 2025, to satisfy tax withholding requirements tied to the vesting of restricted stock units. The transaction involved the sale of 17 shares at $5.10 per share, resulting in $86 in proceeds. Following this transaction…
Peloton Interactive, Inc. (NASDAQ:PTON) interim Chief Financial and Accounting Officer Saqib Baig sold 5,000 shares of the company's Class A Common Stock on June 9, 2026, generating $28,300 at $5.66 per share. The transaction was executed under a Rule 10b5-1 trading plan established on September 2, 2025. Baig retains direct ownership of 234,046.47 …
Mohawk Industries announced that Paul F. De Cock will become CEO on September 30, 2026, succeeding Jeff Lorberbaum, who is retiring after leading the company for 25 years and will remain Chairman. De Cock brings extensive industry experience and has been instrumental in expanding Mohawk's global operations and product portfolio. The leadership tran…
Parabilis Medicines Inc. completed its initial public offering on June 11, 2026, selling 38,525,000 shares at $20.00 per share and exercising the underwriters' overallotment option in full. The IPO generated $770.5 million in gross proceeds before underwriting discounts and offering expenses. In a concurrent private placement, Regeneron Pharmaceuti…
Oportun Financial Corporation announced a significant inducement equity award to its new CEO, Doug Bland, comprising restricted stock units and performance-vesting restricted stock units totaling 927,644 shares. These grants are aimed at incentivizing and retaining the CEO, with a vesting schedule over three years tied to continued service and perf…
Elutia Inc. announced that its CEO and CSO will present at the Planet MicroCap Showcase 2026, focusing on their drug-eluting biomatrix technology designed to mitigate post-surgical infection in implant-based breast reconstruction following mastectomy. The company highlights the potential to improve patient outcomes by reducing complications and rev…
Treace Medical Concepts, Inc., a Nasdaq-listed medical device company specializing in innovative surgical solutions for bunions and midfoot deformities, announced it will present at the Sidoti Small Cap Conference on June 18, 2026. The company is known for its patented Lapiplasty 3D Bunion Correction System and other surgical technologies designed …
Parabilis Medicines, a clinical-stage biopharmaceutical company developing novel medicines targeting historically undruggable proteins, closed its upsized initial public offering on Nasdaq under ticker PBLS at $20 per share. The IPO raised gross proceeds of $770.5 million, including full exercise of underwriters' over-allotment option. Additionally…
Kyntra Bio announced new data from the Phase 3 MATTERHORN trial showing the drug roxadustat significantly improves transfusion independence in patients with anemia due to lower-risk myelodysplastic syndromes (LR-MDS), regardless of ring sideroblast (RS) status. The company is finalizing the protocol for a pivotal Phase 3 trial based on FDA feedback…
CTW, a leading game platform company specializing in anime IP-based free-to-play web games, announced that CFO Patrick Liu will participate and present at the Planet MicroCap Las Vegas 2026 investment conference from June 16-18. The presentation and one-on-one meetings aim to engage investors and showcase CTW's business and growth strategies.
A U.S. federal appeals court on June 11 extended a stay that prevents a lower court ruling from halting the Trump administration's 10% global tariff under Section 122 of the Trade Act, allowing the government to continue collecting the duties from three importers while the appeal proceeds. The affected importers include two small businesses and the…
Ye Weiguo, Chief Operating Officer at Gyre Therapeutics, Inc. (NASDAQ: GYRE), has executed a series of insider sales involving the liquidation of 20,918 shares of the company's common stock. The transactions, which occurred on June 9 and June 10, 2026, resulted in a total value of approximately $128,885. These sales were directly preceded by the ex…
Alphabet is uniquely positioned to monetize the next wave of agentic AI while providing diversified upside through stakes in SpaceX and Anthropic. Fundamentals remain solid (market cap ~$4.34T, EPS $13.14, FCF $64.4B), valuation is reasonable for a compounder, and the current technical pullback offers a tactical entry. Actionable trade plan include…
Nanox Imaging Ltd announces it will release its first quarter 2026 financial results on June 25, 2026, followed by a conference call hosted by CEO Erez Meltzer and CFO Ran Daniel. The company provides an update on its integrated medical imaging platform aimed at expanding preventive healthcare through affordable imaging technology, AI analytics, cl…
Voyager Therapeutics announced that CEO Dr. Alfred W. Sandrock will participate in a pre-recorded fireside chat at the H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference. The webcast will be available on-demand starting June 15, 2026, providing investors and stakeholders insights into the company's programs and strategies.
Ascendis Pharma announced positive five-year Phase 2 data from the PaTH Forward Trial demonstrating that TransCon PTH (palopegteriparatide) provides sustained multi-organ benefits, normalizes calcium levels, improves kidney function and quality of life, and allows independence from conventional therapies in adults with hypoparathyroidism. High pati…
